Improving access to medicines via the Health Impact Fund in India: a stakeholder analysis
Background: In India, 50–65% of the population face difficulties in accessing medicines. The Health Impact Fund (HIF) is a novel proposal whereby pharmaceutical companies would be paid based on the measured global health impact of their drugs. We conducted a key stakeholder analysis to explore acces...
Main Authors: | Patrick McMullan, Vamadevan S. Ajay, Ravi Srinivas, Sandeep Bhalla, Dorairaj Prabhakaran, Amitava Banerjee |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-01-01
|
Series: | Global Health Action |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/16549716.2018.1434935 |
Similar Items
-
Priorities and preferences for school-based mental health services in India: a multi-stakeholder study with adolescents, parents, school staff, and mental health providers
by: R. Parikh, et al.
Published: (2019-01-01) -
Accessing voluntary assisted dying in regional Western Australia: early reflections from key stakeholders
by: Casey Haining, et al.
Published: (2023-10-01) -
Stakeholder perspectives of the future of accessible tourism in New Zealand
by: Brielle Gillovic, et al.
Published: (2015-10-01) -
Perspectives of pharmaceutical stakeholders on determinants of medicines accessibility at the primary care level
by: Hoda Ibrahim Rizk, et al.
Published: (2021-01-01) -
A Stakeholder’s perspective on Holistic Heritage tourism- a special reference to the temple city Bhubaneswar, India.
by: Shruti Mohanty, et al.
Published: (2019-09-01)